Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice

International Journal of Obesity

Volumn 23, Issue 1, 1999, Pages 48-53

  Roe, A L ^a   Howard, G ^b   Blouin, R ^a,b   Snawder, John E ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Cytochrome P450; Glutathione S transferase; ob ob mice; Obesity

Indexed keywords

4 NITROPHENOL; CYTOCHROME P450; ERYTHROMYCIN N DEMETHYLASE; GLUCOSE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; OXYGENASE; RESORUFIN DERIVATIVE; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTRANSFORMATION; CONJUGATION; CONTROLLED STUDY; CYTOSOL; DEALKYLATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; LIVER FUNCTION; LIVER MICROSOME; MALE; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; OBESITY; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE;

ANIMALIA;

EID: 0344272946     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800756     Document Type: Article

References (24)

1. 1 Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 1996; 10: 709-720.
2. 2 Corcoran GB, Wong BK. Obesity as a risk factor in drug-induced organ injury: increased liver and kidney damage by acetaminophen in the obese overfed rat. J Pharmacol Exp Ther 1987; 241: 921-927.
3. 3 Bentley JB, Vaughan RW, Gandolfi AJ, Cork RC. Halothane biotransformation in obese and nonobese patients. Anesthesiology 1982; 57: 94-97.
4. 4 Guengerich FP, Shimada T, Iwasaki M, Butler MA, Kadlubar FF. Activation of carcinogens by human liver cytochromes P-450. Basic Life Sci 1990; 53: 381-396.
5. 5 Raucy JL, Lasker JM, Kraner JC, Salazar DE, Lieber CS, Corcoran GB. Induction of cytochrome P450 IIE1 in the obese overfed rat. Mol Pharmacol 1991; 39: 275-280.
6. 6 Barnett CR, Flatt PR, Ioannides C. Modulation of the rat hepatic cytochrome P450 composition by long-term streptozotocin-induced insulin-dependent diabetes. J Biochem Toxicol 1994; 9: 63-69.
7. 7 Barnett CR, Abbott RA, Bailey CJ, Flatt PR, Ioannedes C. Cytochrome P450-dependent mixed-function oxidase and glutathione 5-transferase activities in spontaneous obesity-induced diabetes. Biochem Pharmacol 1992; 43: 1868-1871.
8. 8 Barnett CR, Rudd S, Flatt PR, Ioannides C. Sex differences in the diabetes-induced modulation of rat hepatic cytochrome P450 proteins. Biochem Pharmacol 1993; 45: 313-319.
9. 9 Chaudhary I, Tuntaterdtum S, McNamara PJ, Robertson LW, Blouin RA. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways. J Pharmacol Exp Ther 1993; 265: 1333-1338.
10. 10 Chlouverakis C, White PA. Obesity and insulin resistance in the obese-hyperglycemic mouse (ob/ob). Metabolism 1969; 18: 998-1006.
11. 11 Roe AL, Snawder JE, Benson RW, Roberts DW, Casciano DA. HepG2 cells: an in vitro model for P450-dependent metabolism of acetaminophen. Biochem Biophys Res Commun 1993; 190: 15-19.
12. 12 Lowry OH, Rosebrough NJ, Farr AL, Randell RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951; 193: 265-275.
13. 13 Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, Mayer RT. Ethoxypentoxy and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 1985; 34: 3337-3345.
14. 14 Snawder JE, Roe AL, Benson RW, Casciano DA, Roberts DW. Cytochrome P450-dependent metabolism of acetaminophen in four human transgenic lymphoblastoid cell lines. Pharmacogen 1994; 4: 43-46.
15. 15 Habig WH, Jakoby WB. Assays for differentiation of glutathione S-transferases. Methods Enzymol 1981; 77: 398-405.
16. 16 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
17. 17 Blouin RA, Bandyopadhyay AM, Chaudhary I, Robertson LW, Gemzik B, Parkinson A. Cytochrome P450 2B enzyme (CYP2B) induction defect following phenobarbital treatment in the fa/fa Zucker rat: molecular characterization. Arch Biochem Biophys 1993; 303: 313-320.
18. 18 Porter TD. Induction and tissue-specific expression of rabbit cytochrome P450 IIE1 and 11E2 genes. Mol Pharm 1989; 36: 61-65.
19. 19 Lundquist I. Differential changes in islet lysosomal enzyme activities in aging obese hyperglycemic mice. Diabetes Res 1986; 3: 25-30.
20. 20 Rouer F, Leroux J-P. Liver microsomal cytochrome P-450 and related monooxygenase activities in genetically hyperglycaemic (ob/ob and db/db) and lean streptozotocin mice. Biochem Pharmacol 1980; 29: 1959-1962.
21. 21 O'Shea D, Davis SN, Kim RB, Wilkinson GR. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther 1994; 56: 359-367.
22. 22 Shapiro BH, Agrawal AK, Pampori NA. Gender differences in drug metabolism regulated by growth hormone. Int J Biochem Cell Biol 1995; 27: 9-20.
23. 23 Abernethy DR, Greenblatt DJ. Drug disposition in obese humans. An update. Clin Pharmacokinet 1986; 11: 199-213.
24. 24 Blouin RA, Kolpek JH, Mann HJ. Influence of obesity on drug disposition. Clin Pharm 1987; 6: 706-714.